OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+0.96%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$824M
AUM Growth
+$824M
(-5.9%)
Cap. Flow
-$26.4M
Cap. Flow
% of AUM
-3.2%
Top 10 Holdings %
Top 10 Hldgs %
74.72%
Holding
32
New
2
Increased
8
Reduced
14
Closed
2
Top Buys
| 1 |
AXDX
Accelerate Diagnostics
AXDX
|
$16M |
| 2 |
BLUE
bluebird bio
BLUE
|
$6.9M |
| 3 |
TTHI
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
|
$3.79M |
| 4 |
Accuray
ARAY
|
$3.31M |
| 5 |
Pacific Biosciences
PACB
|
$2.64M |
Top Sells
| 1 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$16M |
| 2 |
Tenet Healthcare
THC
|
$11.1M |
| 3 |
THOR
THORATEC CORPORATION
THOR
|
$10.1M |
| 4 |
QuidelOrtho
QDEL
|
$7.55M |
| 5 |
Precigen
PGEN
|
$4.56M |
Sector Composition
| 1 | Healthcare | 76.93% |
| 2 | Consumer Staples | 0.18% |
| 3 | Financials | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXDX
1
DELISTED
Accelerate Diagnostics
AXDX
| $140M | 17.02% | 5,394,058 +616,009 | +13% | +$16M |
|
|
2
Tenet Healthcare
THC
$16.3B
| $71.3M | 8.65% | 1,518,876 -237,074 | -14% | -$11.1M |
|
|
ACOR
3
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $65.1M | 7.9% | 1,931,414 -25,000 | -1% | -$843K |
|
|
4
QuidelOrtho
QDEL
$1.95B
| $64.5M | 7.82% | 2,915,633 -341,324 | -10% | -$7.55M |
|
|
MZOR
5
DELISTED
Mazor Robotics Ltd.
MZOR
| $55.4M | 6.73% | 3,154,281 -40,281 | -1% | -$708K |
|
|
NXTM
6
DELISTED
NxStage Medical Inc.
NXTM
| $53.5M | 6.49% | 3,723,407 +124,215 | +3% | +$1.78M |
|
|
THOR
7
DELISTED
THORATEC CORPORATION
THOR
| $51.1M | 6.2% | 1,466,304 -289,900 | -17% | -$10.1M |
|
8
Opko Health
OPK
$1.1B
| $50M | 6.07% | 5,655,738 +83,778 | +2% | +$741K |
|
|
TTHI
9
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
| $32.6M | 3.96% | 4,851,321 +563,909 | +13% | +$3.79M |
|
|
10
Accuray
ARAY
$157M
| $31.8M | 3.86% | 3,616,293 +376,287 | +12% | +$3.31M |
|
|
HNSN
11
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
| $25.6M | 3.11% | 19,546,539 -111,608 | -0.6% | -$146K |
|
12
Ironwood Pharmaceuticals
IRWD
$214M
| $24.8M | 3.02% | 1,620,905 -225,100 | -12% | -$3.45M |
|
|
RPRX
13
DELISTED
Repros Therapeutics Inc.
RPRX
| $21.9M | 2.66% | 1,267,126 +24,800 | +2% | +$429K |
|
|
TSRO
14
DELISTED
TESARO, Inc.
TSRO
| $19.7M | 2.39% | 633,752 | – | – |
|
|
15
Pacific Biosciences
PACB
$393M
| $18.6M | 2.25% | 3,002,508 +426,779 | +17% | +$2.64M |
|
|
VRML
16
DELISTED
Vermillion, Inc.
VRML
| $18.4M | 2.24% | 7,139,960 | – | – |
|
|
WBMD
17
DELISTED
WebMD Health Corp.
WBMD
| $14.5M | 1.76% | 300,141 | – | – |
|
|
BIOL
18
DELISTED
Biolase, Inc.
BIOL
| $13.5M | 1.64% | 6,135,910 | – | – |
|
|
19
Precigen
PGEN
$1.34B
| $9.26M | 1.12% | 368,500 -181,500 | -33% | -$4.56M |
|
|
GTIV
20
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
| $9.07M | 1.1% | 601,960 -245,640 | -29% | -$3.7M |
|
|
BLUE
21
DELISTED
bluebird bio
BLUE
| $6.9M | 0.84% | +178,937 | New | +$6.9M |
|
|
AMRN
22
Amarin Corp
AMRN
$311M
| $6.51M | 0.79% | 3,700,000 +700,000 | +23% | +$1.23M |
|
|
DSCI
23
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $5.7M | 0.69% | 492,796 -7,204 | -1% | -$83.3K |
|
24
Gilead Sciences
GILD
$140B
| $4.15M | 0.5% | 50,000 | – | – |
|
|
AGEN
25
Agenus
AGEN
$133M
| $3.74M | 0.45% | 1,161,134 -214,500 | -16% | -$691K |
|